NSE / ENO2 (Protein | Antibody | cDNA Clone | ELISA Kit)

All NSE / ENO2 reagents are produced in house and quality controlled, including 7 NSE / ENO2 Antibody, 45 NSE / ENO2 Gene, 2 NSE / ENO2 IP Kit, 1 NSE / ENO2 Protein, 1 NSE / ENO2 qPCR. All NSE / ENO2 reagents are ready to use.

NSE / ENO2 Protein (1)

    NSE / ENO2 Antibody (7)

      NSE / ENO2 cDNA Clone (45)

      NSE / ENO2 qPCR Primer (1)

      NSE / ENO2 Background

      The combination of silencing ENO2 and 2-deoxyglucose (2-DG) synergistically inhibited leukemia cell survival. ENO2 may be a biological marker for monitoring chemotherapeutic efficacy and relapse in ALL. Reduced ENO2 expression may be a biomarker for a subset of autistic children. Neuron specific enolase (ENO2, gamma-enolase) has been used as a biomarker to help identify neuroendocrine differentiation in breast cancer.

      NSE / ENO2 References

      • Pechumer H, et al. (1994) Detection of neuron-specific gamma-enolase messenger ribonucleic acid in normal human leukocytes by polymerase chain reaction amplification with nested primers. Lab Invest. 69 (6): 743-9.
      • Craig SP, et al. (1991) Localisation of neurone-specific enolase (ENO2) to 12p13. Cytogenet Cell Genet. 54 (1-2): 71-3.
      • Muley T, et al. (2003) Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay. Clin Chem Lab Med. 41 (1): 95-103.

      Note: Flag® is a registered trademark of Sigma Aldrich Biotechnology LP. It is used here for informational purposes only.